Stockreport

Karyopharm files U.S. application for expanded use of Xpovio [Seeking Alpha]

Karyopharm Therapeutics Inc.  (KPTI) 
Last karyopharm therapeutics inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.karyopharm.com/investor-relations
PDF Karyopharm Therapeutics (NASDAQ:KPTIsubmittedThe FDA approved the SINE compound in July 2019 for relapsed/refractory multiple myeloma.The company also plans to submit a [Read more]